Atezolizumab is an immunotherapy drug used to treat certain types of cancer. It is a monoclonal antibody that works by targeting the protein PD-L1, which helps cancer cells avoid detection by the immune system.
1. What is atezolizumab?
Atezolizumab is an immunotherapy drug that works by targeting a protein called PD-L1. PD-L1 is found on the surface of some cancer cells, helping them evade detection by the immune system. Atezolizumab binds to PD-L1 and prevents it from interacting with other proteins, allowing the immune system to recognize and attack cancer cells. Atezolizumab is used to treat many types of cancer, including lung, bladder, and breast cancer.
2. What are the benefits of atezolizumab?
(1) Atezolizumab is an anticancer drug that works by blocking the action of a protein called PD-L1. This protein is found on the surface of some cancer cells and plays a role in the growth and spread of cancer. Atezolizumab works by binding to PD-L1 and preventing it from doing its job. This helps kill cancer cells or stop them from growing.
(2) Atezolizumab is used to treat lung cancer, bladder cancer and kidney cancer. It is usually given after other treatments have failed.
(3) Atezolizumab has been shown to improve the survival rate of lung cancer patients. It has also been shown to shrink tumors in some people with bladder or kidney cancer.
3. How does atezolizumab work?
Atezolizumab works by targeting a protein called PD-L1. This protein is found on the surface of some cancer cells, and it helps them avoid detection and attack by the immune system. Atezolizumab binds to PD-L1 and stops it from working, allowing the immune system to recognize and attack cancer cells.
Minbiotch Co., Ltd. is committed to the production of biomedicine and a variety of high-end generic drugs and innovative drugs. It is a supplier of atezolizumab. Welcome to visit our website.
